TEVA PHARMACEUTICALS USA, INC. for TEVA PHARMACEUTICALS USA INC
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Copyright/Patent/Trademark CPT
S.214, Preserve Access to Affordable Generics Act; and S.504, A bill to amend the Federal Food, Drug and Cosmetic Act to ensure that valid generic drugs may enter the market
Foreign entity interest: Teva Pharmaceuticals Industries, Ltd., as the indirect parent of Teva Pharmaceuticals USA, Inc., has an interest in the issues listed above.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SUSIE AHN | — |
| DEBRA BARRETT | — |
| GRANT ERDEL | — |
| ROBERT FALB | — |
| TERRI STEWART | — |
Pharmacy PHA
Prescription Drug Abuse, STOPP Act H.R.486; S.Con.Res.8 (FY 2014 Budget) (provisions relating to healthcare and pharmeceuticals); Drug labeling, electronic labeling proposals; access to contraceptives; counterfeit drugs: "track-and-trace," H.R. 1919, Safeguarding America's Pharmaceuticals Act, and S.959, Pharmaceutical Quality, Security and Accountability Act.
Foreign entity interest: Teva Pharmaceuticals Industries, Ltd., as the indirect parent of Teva Pharmaceuticals USA, Inc., has an interest in the issues listed above.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SUSIE AHN | — |
| DEBRA BARRETT | — |
| GRANT ERDEL | — |
| ROBERT FALB | — |
| TERRI STEWART | — |
Trade (domestic/foreign) TRD
Trans-Pacific Partnership Trade Agreement
Foreign entity interest: Teva Pharmaceuticals Industries, Ltd., as the indirect parent of Teva Pharmaceuticals USA, Inc., has an interest in the issues listed above.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DEBRA BARRETT | — |
| GRANT ERDEL | — |
| TERRI STEWART | — |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES, LTD. | Israel | Israel | 100.0% | — |
| ORVET UK | United Kingdom | United Kingdom | 100.0% | — |
| TEVA PHARMACEUTICALS EUROPE BV | Netherlands | Netherlands | 100.0% | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.